2021 Regulatory Predictions for Auto Casualty and Workers’ Comp [Podcast]
On-Demand
In 2020, the workers' compensation and auto casualty regulatory environment was more active than ever—since the start of the COVID-19 pandemic, U.S.
Price Opportunists - Compound Kits and Combo Packs
2 MIN READ
This week’s look back at 2019 drug trends is at compound kits and combo packs.
Prescription and Private Label Topical Trends in 2019
1 MIN READ
These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend.
At the eye of the storm: An opioid overdose epidemic and a viral pandemic converge
2 MIN READ
s 2020 opened, a persistent and tragic opioid overdose epidemic was near the front of a list of national concerns in the US. Some 20+ million Americans are reported to have a substance use disorder and 2M of those misuse opioids.
Opioid Risk Mitigation: Medication-Assisted Treatment (MAT) and Naloxone
2 MIN READ
This week in our in-depth review of our Coventry Drug Trends series, part three, we focus on opioid risk mitigation strategies. While opioids continue to decline in workers’ compensation as both a percentage of total script volume and costs, it remains vital to promote evidence-based strategies such as MAT and naloxone to curb opioid issues.
The Black Lives Matter Movement Is Changing Us for the Better
The first half of 2020 has been unprecedented. There has been some good, a lot of bad and even some ugly. But when I step back and think of one word that sums it all up, it is change. Looking back at where we were as recently as mid-February, our industry was slated for powerful growth and business-as-usual meant powering forward like any other year.
Top 5 Opioid Medication Trends in 2019
1 MIN READ
2019 yielded another year of declines in both opioid utilization and cost. The top 5 opioid medications comprise the majority of all opioid scripts and cost, and their activity can offer further insight into the favorable trends experienced among this impactful therapeutic class.